オランザピン市場レポート：2030年までの動向、予測、競合分析

オランザピンの動向と予測

世界のオランザピン市場は、2024年から2030年までのCAGRが2.1%で、2030年までに推定19億米ドルに達すると予測されます。この市場の主な促進要因は、双極性障害の治療の増加、神経疾患の有病率の上昇、ヘルスケア産業におけるインフラ整備のための政府資金の増加です。世界のオランザピン市場の将来は、双極性障害と統合失調症市場に機会があり、有望視されています。

オランザピン市場洞察

Lucintel社は、経口薬は非侵襲的で患者のコンプライアンスが高く、使いやすく、特別な無菌状態を必要としないため、広く使用されていることから、予測期間中も経口薬がより大きなセグメントであり続けると予測しています。

北米では統合失調症の有病率が増加しているため、オランザピン製剤の需要が増加しており、予測期間中も北米が最大の地域となるでしょう。

よくある質問

Q1.市場規模は？

A1.オランザピンの世界市場は、2030年までに推定19億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.オランザピンの世界市場は、2024年から2030年にかけてCAGR 2.1％で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、双極性障害の治療の増加、神経疾患の有病率の上昇、ヘルスケア産業におけるインフラ整備のための政府資金の増加です。

Q4.市場の主要セグメントは？

A4.オランザピン世界市場の将来は、双極性障害および統合失調症市場における機会により有望です。

Q5.市場の主要企業は？

A5.オランザピンの主要企業は以下の通りです。

• Dr ready's laboratory
• Watson pharmaceuticals
• Lilly
• Hamson pharmaceuticals
• Sun pharmaceuticals
• Sandoz pharmaceuticals
• Torrent pharmaceuticals

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、経口薬は非侵襲的であり、患者のコンプライアンスが高く、使いやすく、特別な無菌状態を必要としないため、広く使用されていることから、予測期間中、経口薬がより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、同地域における統合失調症の有病率の増加に起因するオランザピン治療薬の需要の増加により、予測期間中も最大の地域です。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のオランザピン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のオランザピン市場動向（2018-2023）と予測（2024-2030）
• 投与経路別の世界のオランザピン市場
  • 経口
  • 非経口
• 用途別の世界のオランザピン市場
  • 双極性障害
  • 統合失調症
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のオランザピン市場
• 北米オランザピン市場
• 欧州のオランザピン市場
• アジア太平洋のオランザピン市場
• その他地域のオランザピンマーケット

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 投与経路別の世界のオランザピン市場の成長機会
  • アプリケーション別の世界のオランザピン市場の成長機会
  • 地域別の世界のオランザピン市場の成長機会
• 世界のオランザピン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のオランザピン市場の能力拡大
  • 世界のオランザピン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Dr ready's laboratory
• Watson pharmaceuticals
• Lilly
• Hamson pharmaceuticals
• Sun pharmaceuticals
• Sandoz pharmaceuticals
• Torrent pharmaceuticals

Olanzapine Trends and Forecast

The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets. The global olanzapine market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 2.1% from 2024 to 2030. The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

A more than 150-page report is developed to help in your business decisions.

Olanzapine by Segment

The study includes a forecast for the global olanzapine by route of administration, application, and region.

Olanzapine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Parenteral

Olanzapine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Bipolar Disorder
• Schizophrenia
• Others

Olanzapine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Olanzapine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies olanzapine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the olanzapine companies profiled in this report include-

• Dr ready's laboratory
• Watson pharmaceuticals
• Lilly
• Hamson pharmaceuticals
• Sun pharmaceuticals
• Sandoz pharmaceuticals
• Torrent pharmaceuticals

Olanzapine Market Insights

Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Features of the Global Olanzapine Market

Market Size Estimates: Olanzapine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Olanzapine market size by route of administration, application, and region in terms of value ($B).

Regional Analysis: Olanzapine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, application, and regions for the olanzapine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the olanzapine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the olanzapine market size?

Answer: The global olanzapine market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for olanzapine market?

Answer: The global olanzapine market is expected to grow with a CAGR of 2.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the olanzapine market?

Answer: The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

Q4. What are the major segments for olanzapine market?

Answer: The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets.

Q5. Who are the key olanzapine market companies?

Answer: Some of the key olanzapine companies are as follows.

• Dr ready's laboratory
• Watson pharmaceuticals
• Lilly
• Hamson pharmaceuticals
• Sun pharmaceuticals
• Sandoz pharmaceuticals
• Torrent pharmaceuticals

Q6. Which olanzapine market segment will be the largest in future?

Answer: Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

Q7. In olanzapine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the olanzapine market by route of administration (oral and parenteral), application (bipolar disorder, schizophrenia, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Olanzapine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Olanzapine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Olanzapine Market by Route of Administration
  • 3.3.1: Oral
  • 3.3.2: Parenteral
• 3.4: Global Olanzapine Market by Application
  • 3.4.1: Bipolar disorder
  • 3.4.2: Schizophrenia
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Olanzapine Market by Region
• 4.2: North American Olanzapine Market
  • 4.2.2: North American Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
• 4.3: European Olanzapine Market
  • 4.3.1: European Olanzapine Market by Route of Administration: Oral and Parenteral
  • 4.3.2: European Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
• 4.4: APAC Olanzapine Market
  • 4.4.1: APAC Olanzapine Market by Route of Administration: Oral and Parenteral
  • 4.4.2: APAC Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
• 4.5: ROW Olanzapine Market
  • 4.5.1: ROW Olanzapine Market by Route of Administration: Oral and Parenteral
  • 4.5.2: ROW Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Olanzapine Market by Route of Administration
  • 6.1.2: Growth Opportunities for the Global Olanzapine Market by Application
  • 6.1.3: Growth Opportunities for the Global Olanzapine Market by Region
• 6.2: Emerging Trends in the Global Olanzapine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Olanzapine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Olanzapine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Dr ready's laboratory
• 7.2: Watson pharmaceuticals
• 7.3: Lilly
• 7.4: Hamson pharmaceuticals
• 7.5: Sun pharmaceuticals
• 7.6: Sandoz pharmaceuticals
• 7.7: Torrent pharmaceuticals